Curexsys Overview
- Year Founded
-
2017
- Status
-
Out of Business
- Employees
-
8
- Latest Deal Type
-
Liquidation
Curexsys General Information
Description
Developer of exosomes as therapeutics designed to cure age-related diseases and to address rejuvenation and anti-aging. The company specializes in delivering automated proprietary isolation technology for exosomes, based on a traceless immune-affinity process, which is different from commonly used antibody-based processes, enabling physicians to overcome a key hurdle in exosome preparation.
Contact Information
Website
www.curexsys.comCorporate Office
- Annastraße 27
- 37075 Gottingen
- Germany
Corporate Office
- Annastraße 27
- 37075 Gottingen
- Germany
Curexsys Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Bankruptcy: Liquidation | 26-Apr-2024 | Completed | Out of Business | |||
| 1. Early Stage VC (Series A) | 14-Dec-2020 | Completed | Generating Revenue |
Curexsys Signals
Curexsys FAQs
-
When was Curexsys founded?
Curexsys was founded in 2017.
-
Where is Curexsys headquartered?
Curexsys is headquartered in Gottingen, Germany.
-
What is the size of Curexsys?
Curexsys has 8 total employees.
-
What industry is Curexsys in?
Curexsys’s primary industry is Biotechnology.
-
Is Curexsys a private or public company?
Curexsys is a Private company.
-
What is Curexsys’s current revenue?
The current revenue for Curexsys is .
-
How much funding has Curexsys raised over time?
Curexsys has raised $9.8M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process